Hypomorphic <i>ACP5</i> mutations impair endochondral bone growth and create an interferon (INF) signature, which lead to distinctive spondylar and metaphyseal dysplasias, and extraskeletal morbidity, such as neurological involvement and immune dysregulation, respectively. The gene discussed is ACP5; the disease is dysplasia.